drugset / Trial / NCT01688401
Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).
Phase 1
Completed
3 enrolled
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Solving Kids' Cancer · collab
NaSingle-groupOpen-labelOther
Summary
The goal of this pilot study is to determine if intra-arterial (IA) chemotherapy is safe in the treatment of progressive diffuse intrinsic pontine gliomas (DIPG). IA administration of the chemotherapeutic agent enhances the regional distribution of the drug, thereby increasing the local delivered dose while minimizing systemic toxicity. It also provides a treatment option for these patients at the time of tumor recurrence.
Timeline
- Start
- 2013-03-08
- Primary completion
- 2017-05
- Completion
- 2018-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melphalan | Small molecule | 2 mg | Other |